Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Baxdrostat for uncontrolled hypertension (including resistant hypertension) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Baxdrostat (Baxdrostat)

Snippet

Sponsor: AstraZeneca | Conditions: Uncontrolled Hypertension, Resistant Hypertension | Phase 3 | Status: COMPLETED